Unknown Ravikash

Dimitrios Kambouris Elon Musk’s brain-implant company Neuralink said in a tweet that it received approval from the U.S. Food and Drug Administration to conduct human clinical trials of the device. "This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," Neuralink tweeted. The company is developing a device, which is to be implanted in the skull, and will link the brain to the computer. The brain-computer interface is fully implantable, cosmetically invisible, and designed to let the person control a computer or mobile device anywhere they go, according to the company. Neuralink noted in the social media post that recruitment is not yet open for its clinical trial. However, on its website the company has a Patient Registry. Anyone within the U.S. who is at least 18 years old, who is able to consent, and who has quadriplegia, paraplegia, vision loss, hearing loss, and/or is unable to speak, can participate in the Patient Registry, as per the company. Neuralink adds that while there is no direct benefit from participating in the Patient Registry, the company may contact the people about future Neuralink clinical trials they may be eligible for, when the trials become available. Those registering may potentially benefit in the future from research coming out of the Patient Registry and any commercial products. Neuralink from Billionaire Musk — who is also CEO of Tesla (TSLA) and SpaceX (SPACE) and owner of social media company Twitter — is not the only company working on brain-computer interface. Synchron, which is backed by Microsoft (MSFT) Co-Founder Bill Gates and Amazon.com (AMZN) Founder Jeff Bezos, has already started enrolling patients in trial of Switch — a brain-computer interface device implanted via blood vessels which allows people with no or limited mobility to operate technology such as mobile devices and computers using their thoughts. More on Tesla Tesla Stock: You Have Been Pumped And Warned By Elon Musk Tesla Sell Signals Confirmed (Technical Analysis, Downgrade)

40%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a poor reputation for journalistic standards and is not considered a reliable news source.

Bias

10%

Examples:

  • The article is biased in favor of Neuralink and Elon Musk by not mentioning their competitors or the potential risks of brain-computer interface technology.

Conflicts of Interest

50%

Examples:

  • The article mentions Tesla and SpaceX but does not disclose their connection to Neuralink or Elon Musk. It also uses audioundwerbung/iStock via Getty Images without citing the source.

Contradictions

85%

Examples:

  • The article contradicts itself by claiming that Neuralink received FDA approval and then saying that recruitment is not yet open for its clinical trial. It also exaggerates the benefits of the device without providing any evidence or context.

Deceptions

50%

Examples:

  • The article is deceptive by presenting Neuralink as a credible and successful company without providing any details or data to support its claims. It also uses vague terms like 'incredible work' and 'important first step' without explaining what they mean.

Recent Articles

Plug Power Stock Keeps Rolling: Is It Time to Buy?

Plug Power Stock Keeps Rolling: Is It Time to Buy?

Broke On: Sunday, 04 February 2024 Plug Power Stock Soars on Green Hydrogen Milestone, But Challenges Remain The stock of Plug Power (PLUG), a leading provider of hydrogen energy solutions, has surged in the past week as it announced its first shipment of liquid green hydrogen from a new plant in Georgia. This marks an important step for the company and the green hydrogen industry, which faces supply chain issues and cash flow problems. However, investors should be aware that Plug Power still needs to build more facilities to sustain its growth and profitability.